Articles by James P. Catania - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by James P. Catania

Quality by Design: The Case for Change (Part II)

A rigorous cost-benefit assessment can help to chart a cost-effective path forward.
May 1, 2011

A rigorous cost-benefit assessment can help to chart a cost-effective path forward.

Quality by Design: The Case for Change

Executive management leadership is essential in the effective implementation of QbD
Mar 1, 2011

Executive management leadership is essential in the effective implementation of QbD.

How to Reduce Unnecessary Compliance Costs

By identifying and eliminating non-value-added activities, drug manufacturers can avoid falling into the same cost-traps in the future.
Jul 1, 2010

By identifying and eliminating non-value-added activities, drug manufacturers can avoid falling into the same cost-traps in the future.

ADVERTISEMENT

ADVERTISEMENT

Click here